↓ Skip to main content

Clinical Trials of Immunomodulation in Ischemic Stroke

Overview of attention for article published in Neurotherapeutics, October 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (84th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

blogs
1 blog
twitter
2 X users
patent
2 patents

Citations

dimensions_citation
96 Dimensions

Readers on

mendeley
102 Mendeley
Title
Clinical Trials of Immunomodulation in Ischemic Stroke
Published in
Neurotherapeutics, October 2016
DOI 10.1007/s13311-016-0458-y
Pubmed ID
Authors

Roland Veltkamp, Dipender Gill

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 102 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 102 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 19 19%
Researcher 16 16%
Student > Bachelor 11 11%
Student > Master 8 8%
Other 6 6%
Other 18 18%
Unknown 24 24%
Readers by discipline Count As %
Neuroscience 25 25%
Medicine and Dentistry 13 13%
Biochemistry, Genetics and Molecular Biology 11 11%
Agricultural and Biological Sciences 8 8%
Pharmacology, Toxicology and Pharmaceutical Science 4 4%
Other 11 11%
Unknown 30 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 January 2021.
All research outputs
#3,129,549
of 25,837,817 outputs
Outputs from Neurotherapeutics
#299
of 1,328 outputs
Outputs of similar age
#50,543
of 334,313 outputs
Outputs of similar age from Neurotherapeutics
#7
of 15 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,328 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 18.5. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 334,313 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.